Manager × security

Lynx1 Capital Management LP STOK holdings history

Who else holds this security? →

STOKE THERAPEUTICS INC · CUSIP 86150R107 · CIK 1910456

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Lynx1 Capital Management LP reported 4.04M STOK (shares), valued at $132.14M, or 15.27% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
15.27%
Shares
4.04M
4,038,404
Reported value
$132.14M
USD

Shares decreased 15.22%; reported value decreased 14.81%, and weight changed -9.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202615.27%4,038,404SEC filing ↗Filed Aug 13, 2026Amended
Q1 202624.51%4,763,673SEC filing ↗Filed May 4, 2026
Q4 202534.73%5,404,674SEC filing ↗Filed Feb 17, 2026
Q3 202522.37%5,404,674SEC filing ↗Filed Nov 13, 2025
Q2 202517.72%5,404,674SEC filing ↗Filed Aug 14, 2025
Q1 202512.60%5,291,929SEC filing ↗Filed May 15, 2025
Q4 202421.45%5,187,191SEC filing ↗Filed Feb 14, 2025
Q3 202422.59%5,187,191SEC filing ↗Filed Nov 14, 2024
Q2 202425.27%5,185,191SEC filing ↗Filed Aug 14, 2024Amended
Q1 202412.85%3,696,820SEC filing ↗Filed May 15, 2024Amended
Q4 20236.12%2,956,918SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20236.12%2,956,918$15.55MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 202412.85%3,696,820$49.91MShares increased 25.02%; reported value increased 220.88%, and weight changed +6.73 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 202425.27%5,185,191$70.05MShares increased 40.26%; reported value increased 40.36%, and weight changed +12.42 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 202422.59%5,187,191$63.75MShares increased 0.04%; reported value decreased 9.00%, and weight changed -2.68 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 202421.45%5,187,191$57.21MShares unchanged; reported value decreased 10.25%, and weight changed -1.14 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 202512.60%5,291,929$35.19MShares increased 2.02%; reported value decreased 38.49%, and weight changed -8.85 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 202517.72%5,404,674$61.34MShares increased 2.13%; reported value increased 74.31%, and weight changed +5.12 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202522.37%5,404,674$109.88MShares unchanged; reported value increased 79.13%, and weight changed +4.65 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 202534.73%5,404,674$171.54MShares unchanged; reported value increased 56.12%, and weight changed +12.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 202624.51%4,763,673$155.11MShares decreased 11.86%; reported value decreased 9.58%, and weight changed -10.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 4, 2026
Q2 202615.27%4,038,404$132.14MShares decreased 15.22%; reported value decreased 14.81%, and weight changed -9.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
Lynx1 Capital Management LP · STOKE THERAPEUTICS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1910456","quarter":"2026Q2","cusip":"86150R107"}

get_institutional_manager_history
{"cik":"1910456","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.